Marksans Pharma Ltd

NSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Marksans Pharma Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
81.01% Gain from 52W Low
10.5
TTM PE Ratio
Below industry Median
23.2
Price to Book Ratio
Above industry Median
3.5
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is much higher than 1
1.3
RSI
RSI is mid-range
53
MFI
MFI oversold
28.8

Marksans Pharma Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Marksans Pharma Ltd shareholding Pattern

Promoter
43.8%
Foreign Institutions
15.6%
Mutual Funds
4.2%
Domestic Institutions
5.2%
Public
35.4%
Promoter
43.8%
Foreign Institutions
15.6%
Mutual Funds
3.8%
Domestic Institutions
4.8%
Public
35.8%
Promoter
43.8%
Foreign Institutions
15.1%
Mutual Funds
3.2%
Domestic Institutions
4%
Public
37.1%
Promoter
43.8%
Foreign Institutions
14.9%
Mutual Funds
2.8%
Domestic Institutions
3.6%
Public
37.6%
Promoter
43.8%
Foreign Institutions
15.1%
Mutual Funds
0.9%
Domestic Institutions
1.5%
Public
39.6%
Promoter
49%
Foreign Institutions
4.2%
Mutual Funds
1%
Domestic Institutions
1%
Public
45.8%

Marksans Pharma Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
15
Bearish Moving Averages
1
5Day EMA
157.80
10Day EMA
156.60
12Day EMA
156.60
20Day EMA
157.40
26Day EMA
158.00
50Day EMA
158.60
100Day EMA
155.50
200Day EMA
143.00
5Day SMA
157.80
10Day SMA
153.30
20Day SMA
158.20
30Day SMA
159.20
50Day SMA
162.10
100Day SMA
156.90
150Day SMA
156.30
200Day SMA
144.20
Delivery & Volume
Resistance & Support
160.80
Pivot
Resistance
First Resistance
163.43
Second Resistance
166.04
Third Resistance
168.67
Support
First Support
158.19
Second support
155.56
Third Support
152.95
Relative Strength Index
53.03
Money Flow Index
28.83
MACD
-1.40
MACD Signal
-2.14
Average True Range
7.39
Average Directional Index
21.96
Rate of Change (21)
-2.44
Rate of Change (125)
-0.63
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
FDC Ltd.
7509.62
304.5
489.95
Neuland Laboratories Ltd.
8325.12
2727
7790
Orchid Pharma Ltd.
-
-
-
Sun Pharma Advanced Research Company Ltd.
7602.57
191.3
472.8
Aarti Pharmalabs Ltd.
5493.3
320.3
638.75
Blue Jet Healthcare Ltd
6798.98
319.5
433.4

Marksans Pharma Ltd Company background

Founded in: 1992
Managing director: Mark Saldanha
Marksans Pharma Limited is a public limited company incorporated in the year April 16th, 1982. The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation. The Companys research and development facilities are located in Verna, Goa and R D center in Navi Mumbai.The Company on 30th March 2015, issued and allotted 240,06,494 equity shares of Rs1/ each to qualified institutional buyers under QIP for cash at Rs54.67 (including premium) per Equity Share. In accordance to terms of issue, the Directors in their meeting held on 7th February, 2015 decided to redeem entire 13,50,000 7% Redeemable Cumulative Preference Shares of face value Rs100/ per share at par out of profits in tranches before due date of redemption i.e 27th March, 2018. Accordingly, on 7th February 2015, the Directors redeemed 1,00,000 preference shares at par.The Company issued 50,000 Bonds of USD 1,000 each in principal value during the financial year 2015. As on date of report, the Company bought back and extinguished 49,939 Bonds. Of which, only 61 Bonds of USD 1,000 each in principal value (out of total 50,000 Bonds issued) remained outstanding as the same are not traceable During the year 2017, the Company redeemed 1,50,000 preference shares of Rs100/each at par. Accordingly, issued, subscribed and paidup preference share capital reduced from 12,50,000 preference shares of Rs100/ each to 11,00,000 preference shares of Rs100/ each with effect from 31st March 2017.
Read More

Marksans Pharma Ltd FAQs

Marksans Pharma Ltd shares are currently priced at 160.83 on NSE and 160.85 on BSE as of 6/13/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Marksans Pharma Ltd [MARKSANS] share was 79.09. The Marksans Pharma Ltd [MARKSANS] share hit a 1-year low of Rs. 86.3 and a 1-year high of Rs. 185.5.

The market cap of Marksans Pharma Ltd is Rs. 7288.23 Cr. as of 6/13/2024 12:00:00 AM.

The PE ratios of Marksans Pharma Ltd is 54.53 as of 6/13/2024 12:00:00 AM.

The PB ratios of Marksans Pharma Ltd is 5.96 as of 6/13/2024 12:00:00 AM

The Mutual Fund Shareholding was 4.23% at the end of 6/13/2024 12:00:00 AM.

You can easily buy Marksans Pharma Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage